# Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

> **NCT01149330** · PHASE4 · COMPLETED · sponsor: **Galderma Brasil Ltda.** · enrollment: 75 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene-BPO Gel

## Key facts

- **NCT ID:** NCT01149330
- **Lead sponsor:** Galderma Brasil Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2012-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149330, "Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01149330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*